Effect of Metformin and Myo-Inositol in Patients with Polycystic Ovary Syndrome

    Hanaa Fathi Abo Ria, Hanan Abd El-Monem Mohammed, Hoda Ismail Sayed Hemida
    Studysummary This study found that combining metformin with myo-inositol improved outcomes for women with Polycystic Ovary Syndrome, resulting in a statistically significant increase in normal ovarian size and higher pregnancy rates compared to treatment with metformin alone.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on aimj.researchcommons.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Prevalence of Hyperandrogenemia in Polycystic Ovary Syndrome Diagnosed by the National Institutes of Health 1990 Criteria Fertility and Sterility · 2009

    Related research 1

    1. Metformin: An Old Medication of New Fashion: Evolving New Molecular Mechanisms and Clinical Implications in Polycystic Ovary Syndrome European journal of endocrinology · 2009